1962
DOI: 10.1146/annurev.me.13.020162.001341
|View full text |Cite
|
Sign up to set email alerts
|

Insulin Resistance in Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

1970
1970
2014
2014

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(6 citation statements)
references
References 0 publications
0
6
0
Order By: Relevance
“…The fasting elevated plasma glucose and low insulin levels (Table 1) are features of type 2 diabetes (1), which is characterized by insulin resistance, impaired β-cell function, and glucose regulation, leading to β-cell failure. In the case of type 2 diabetes, functional β-cells vary in numbers, with gradual progressive apoptosis in the advanced stages.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…The fasting elevated plasma glucose and low insulin levels (Table 1) are features of type 2 diabetes (1), which is characterized by insulin resistance, impaired β-cell function, and glucose regulation, leading to β-cell failure. In the case of type 2 diabetes, functional β-cells vary in numbers, with gradual progressive apoptosis in the advanced stages.…”
Section: Discussionmentioning
confidence: 99%
“…In the early type 2 diabetes, the insulin resistance, characterized by defects in the insulin signaling pathway (28), elicits a compensatory increase in pancreatic insulin secretion and higher than normal plasma insulin levels. As the disease progresses, insulin release from the pancreas becomes reduced, because of apoptosis and decrease in β-cell numbers in the later stages, resulting in lower than normal plasma insulin levels and hyperglycemia (1,29). The apoptosis of pancreatic islet β-cells in type 2 diabetes differentiates it from the necrosis of β-cells seen in type 1 diabetes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…21,22 Historically, the earliest indication of the association between inflammation and insulin resistance goes back to the observations made in the late 1950s when an elusive "insulin antagonist" activity was described in the serum of a patient suffering from foot gangrene and infection; when this patient's serum was transferred to mice, it could antagonize the hypoglycemic effects of insulin. [23][24][25] In the 1980s, Feingold and Grunfeld demonstrated that infection or administration of tumor necrosis factor α (TNFα), a pro-inflammatory cytokine, caused dyslipidemia and metabolic abnormalities. 26,27 Bagby and Lang also demonstrated the impact of TNFα administration in inducing insulin resistance.…”
Section: Evolutionary Connections Between Metabolism and Immunitymentioning
confidence: 99%
“…In cases of insulin resistance, which may be caused by antibody formation to animal insulins (Field, 1962), the use of insulins which are structurally closer to human insulin or less antigenic than beef or pork insulins is sometimes successful. De-alinated pork insulin (Akre et al, 1964), sulphated pork insulin (Little and Amott, 1966), and fish insulin (Jayarao et al, 1969) have been used for this purpose, but are not readily available.…”
Section: Special Insulinsmentioning
confidence: 99%